<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00724204</url>
  </required_header>
  <id_info>
    <org_study_id>Safety Salivarius</org_study_id>
    <nct_id>NCT00724204</nct_id>
  </id_info>
  <brief_title>Safety Assessment of Lactobacillus Salivarius CECT5713 in 6 Months Old Children</brief_title>
  <acronym>P010</acronym>
  <official_title>Functional Evaluation of a Follow on Formula Supplemented With Lactobacillus Salivarius CECT5713</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Puleva Biotech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Clinico Universitario San Cecilio</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Puleva Biotech</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the trial is to evaluate safety of a follow on formula supplemented with
      Lactobacillus salivarius CECT5713. A randomized double blind placebo controlled trial was
      carried out. Eighty six months old children were recruited by the department of pediatrics of
      Hospital Univeristario San Cecilio. Children were divided in two groups that consumed a
      follow on formula supplemented or not with the probiotic strain during 6 months. Fecal
      samples were obtained at the recruitment, at 3 months and at the end of the trial. In
      addition revision by the pediatrician was performed once a month and possible adverse effects
      were recorded both by the pediatrician and by parents.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse reactions</measure>
    <time_frame>3 months and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>growth parameters (height, length, head circumference)</measure>
    <time_frame>3 months and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiota</measure>
    <time_frame>3 months and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal short chain fatty acids</measure>
    <time_frame>3 months and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Children that consumed a follow on formula without Lactobacillus salivarius CECT5713</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children that consumed a follow on formula with Lactobacillus salivarius CECT5713</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>follow on formula without probiotics</intervention_name>
    <description>A follow on formula without probiotics</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>follow on formula with Lactobacillus salivarius CECT5713</intervention_name>
    <description>follow on formula with Lactobacillus salivarius CECT5713 in a dose of 2x10E8 cfu/day</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy six months old children

        Exclusion Criteria:

          -  Lactose intolerance

          -  Cow's milk protein allergy

          -  Serious metabolic diseases

          -  Antibiotic treatment

          -  Serious gastrointestinal diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>José A Maldonado, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics. Hospital Universitario San Cecilio</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mónica Olivares, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Nutrition and Health. Puleva Biotech. Granada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Federico Lara-Villoslada, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Nutrition and Helath. Puleva Biotech. Granada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario San Cecilio</name>
      <address>
        <city>Granada</city>
        <zip>18012</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2008</study_first_submitted>
  <study_first_submitted_qc>July 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2008</study_first_posted>
  <last_update_submitted>July 28, 2008</last_update_submitted>
  <last_update_submitted_qc>July 28, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2008</last_update_posted>
  <responsible_party>
    <name_title>Federico Lara-Villoslada</name_title>
    <organization>Puelav Biotech</organization>
  </responsible_party>
  <keyword>probiotics</keyword>
  <keyword>safety</keyword>
  <keyword>fecal microbiota</keyword>
  <keyword>infections</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

